Switzerland Investment Grade Healthcare & Pharmaceuticals Corporate Bond Yields (USD)
Fitted spot curve as of 2026-10-26
https://bondscovery.com/yield-curve/usd-corporate-healthcare-pharmaceuticals-switzerland
Switzerland Investment Grade Healthcare & Pharmaceuticals Corporate Bond Yields (USD) as of 2026-10-26: 10Y at 5.65%, fitted curve 1M–30Y (4.38%–5.99%), 63 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 1M | 4.38% | — |
| 3M | 4.44% | 4.47% |
| 6M | 4.52% | 4.71% |
| 2Y | 4.87% | 5.06% |
| 3Y | 5.01% | 5.37% |
| 4Y | 5.13% | 5.61% |
| 5Y | 5.24% | 5.83% |
| 6Y | 5.34% | 6.03% |
| 7Y | 5.43% | 6.20% |
| 8Y | 5.51% | 6.34% |
| 9Y | 5.59% | 6.45% |
| 10Y | 5.65% | 6.53% |
| 15Y | 5.88% | 6.73% |
| 20Y | 5.97% | 6.57% |
| 25Y | 5.97% | 6.12% |
| 30Y | 5.99% | 6.25% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 4.87% and the 10-year 5.65%, a 10Y−2Y spread of +78 bp — positively sloped — as of 2026-10-26. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-10-26 | 1m ago2026-09-25 | 2m ago2026-08-27 | 3m ago2026-07-28 | 4m ago2026-06-29 | 5m ago2026-05-29 | 6m ago2026-04-29 |
|---|---|---|---|---|---|---|---|
| 2Y | 4.87% | 5.02% | 4.49% | 4.52% | 4.37% | 4.35% | 4.15% |
| 10Y | 5.65% | 5.78% | 5.26% | 5.28% | 4.99% | 5.07% | 4.99% |
| 10Y − 2Y | +78 bp | +75 bp | +77 bp | +75 bp | +63 bp | +72 bp | +84 bp |
Bonds in this curve
A selection of 30 of the 63 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Roche Holding | 4.55% | 2026-11-13 | 5.26% | US771196CE02 |
| Roche Holding | 4.66% | 2027-01-28 | 2.38% | USU75000BL90 |
| Novartis | 4.08% | 2027-02-14 | 2.00% | US66989HAQ11 |
| Roche Holding | 4.49% | 2027-03-10 | 2.31% | US771196BV36 |
| Novartis | 4.53% | 2027-05-17 | 3.10% | US66989HAN89 |
| Roche Holding | 4.90% | 2028-09-17 | 3.62% | USU75000BP05 |
| Novartis | 4.87% | 2028-11-05 | 3.90% | US66989HAX61 |
| Roche Holding | 5.12% | 2029-09-09 | 4.20% | US771196CP58 |
| Novartis | 4.96% | 2029-09-18 | 3.80% | US66989HAT59 |
| Novartis | 5.07% | 2030-08-14 | 2.20% | US66989HAR93 |
| Roche Holding | 5.23% | 2030-11-13 | 5.49% | USU75000CG96 |
| Novartis | 5.14% | 2031-09-18 | 4.00% | US66989HAU23 |
| Roche Holding | 5.19% | 2031-12-13 | 2.08% | USU75000BX39 |
| Novartis | 5.27% | 2032-11-05 | 4.30% | US66989HAZ10 |
| Roche Holding | 5.35% | 2032-12-02 | 4.37% | US771196CT70 |
| Roche Holding | 5.43% | 2033-11-13 | 5.59% | USU75000CH79 |
| Roche Holding | 5.44% | 2034-03-08 | 4.99% | USU75000CL81 |
| Roche Holding | 5.39% | 2034-09-09 | 4.59% | USU75000CQ78 |
| Novartis | 5.34% | 2034-09-18 | 4.20% | US66989HAV06 |
| Novartis | 5.53% | 2035-11-05 | 4.60% | US66989HBA59 |
| Novartis | 5.59% | 2036-03-18 | 4.90% | US66989HBJ68 |
| Roche Holding | 5.79% | 2039-03-01 | 7.00% | US771196AU61 |
| Roche Holding | 5.64% | 2039-03-01 | 7.00% | USU75000AN65 |
| Novartis | 5.92% | 2042-09-21 | 3.70% | US66989HAF55 |
| Novartis | 5.97% | 2044-05-06 | 4.40% | US66989HAH12 |
| Roche Holding | 5.89% | 2044-11-28 | 4.00% | USU75000BG06 |
| Roche Holding | 5.92% | 2051-12-13 | 2.61% | USU75000BY12 |
| Roche Holding | 5.95% | 2054-03-08 | 5.22% | USU75000CM64 |
| Novartis | 5.97% | 2055-11-05 | 5.30% | US66989HBC16 |
| Novartis | 6.03% | 2056-03-18 | 5.70% | US66989HBL15 |